|
|
|
Kyverna Therapeutics Inc (NASDAQ: KYTX) |
|
KYTX's Market share relative to its competitors, as of Q1 2025
As of Q1 2025 (Revenue in Millions of $)
Date modified: 2025-04-12T22:43:48+00:00
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
REVENUES
12 Months Ending
Q1 2025 |
MARKET SHARE
12 Months
Q1 2025 |
MARKET SHARE
MRQ
Q1 2025 |
MARKET SHARE
A Quarter Before
Q4 2024 |
| Kyverna Therapeutics Inc |
0.00 |
0.00% |
0.00 % |
0.00 % |
| Immix Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| SUBTOTAL |
0.00 |
100% |
0.00 |
100% |
KYTX's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
As of Q1 2025
| COMPANY NAME |
MARKET SHARE
12 Months Ending
Q1 2025 |
MARKET SHARE
12 Months Ending
Q4 2024 |
MARKET SHARE
MRQ
Q1 2025 |
MARKET SHARE
Q4 2024 |
| Kyverna Therapeutics Inc |
0.00% |
0.00% |
0.00 % |
0.00 % |
| Immix Biopharma Inc |
0.00% |
0.00% |
0.00% |
0.00% |
| SUBTOTAL |
100% |
100% |
100% |
100% |
Note: Market share is calculated based on total revenue. To get a more accurate picture of Kyverna Therapeutics Inc's market divisions, geographic dispersion, segments, products, and services, visit Kyverna Therapeutics Inc's Business Segment. The list includes publicly traded companies only. More information about the sources of this report can be found here. |
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
